M
MannKind Corporation
Biopharmaceutical company that focuses on the development and commercialization of therapeutic products
About MannKind Corporation
MannKind Corporation is a biopharmaceutical company focused on developing and commercializing innovative therapeutic products and devices for people living with endocrine and orphan lung diseases. The company leverages cutting-edge technology and a team of solution-based scientists and medical professionals dedicated to improving the quality of life for patients. MannKind's flagship product, Afrezza, is an FDA-approved rapid-acting inhaled insulin for diabetes management. The company operates in the healthcare sector, primarily serving patients, healthcare providers, and medical institutions. MannKind generates revenue through the sale of its therapeutic products and devices, as well as through partnerships and collaborations with other pharmaceutical companies. The business model is centered around continuous innovation, regulatory approvals, and strategic partnerships to expand its market reach and product offerings.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 1991
- Headquarters
- Santa Clarita, United States
- Listing
- IPO 2004
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Breakthrough T1D
Series B and later2 investors entered at this stage
Blackstone
Frazier Life Sciences
Source: Dealroom Talent Intelligence.
Global footprint
across markets
Patents
109 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about MannKind Corporation on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MannKind Corporation on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.